SeekingAlpha
Discover Cellectis SA's innovative CAR T-cell therapies targeting heme malignancies & upcoming 2025 catalysts.
Yahoo
(Article 223-16 of General Regulation of the French financial markets authority)PARIS, April 07, 2025 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting rights03/31/2025100,290,07889,046,759 For further information on Cellectis, please contact: Media contacts: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77
Yahoo
As European markets navigate a landscape marked by hopes of increased government spending and trade-related uncertainties, the pan-European STOXX Europe 600 Index recently ended higher after two weeks of losses. For investors willing to explore beyond large-cap stocks, penny stocks—often associated with smaller or newer companies—remain a relevant investment area despite the term's somewhat outdated feel. This article highlights three European penny stocks that could offer intriguing...
SeekingAlpha
Cellectis S.A. (NASDAQ:CLLS) Q4 2024 Earnings Conference Call March 14, 2025 8:00 AM ETCompany ParticipantsArthur Stril - CFO and Chief Business...
Yahoo
○ UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) granted by FDA and ODD granted by the European Commission to UCART22 for the treatment of ALL. ○ UCART20x22 Phase 1 study in relapsed or refractory B-cell non-Hodgkin lymphoma (r/r NHL) ongoing with readout expected in late 2025. ○ AstraZeneca partnership: R&D activities ongoing on three programs – one allogeneic CAR T fo
Yahoo
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial results for the fourth quarter and full year 2024 ending December 31, 2024 on Thursday, March 13, 2025 after the close of the US market. The publication will be followed by an investor conference call and webcast
Current Value
$1.481 Year Return
Current Value
$1.481 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | -24.80% | $173.44M | 0.5% |
BTAL | -22.50% | $361.41M | 1.43% |
UUP | -17.00% | $292.27M | 0.77% |
VIXY | -16.85% | $109.64M | 0.85% |
TAIL | -16.09% | $140.49M | 0.59% |
KMLM | -10.88% | $188.32M | 0.9% |
XHLF | -8.34% | $1.46B | 0.03% |
SGOV | -8.00% | $45.91B | 0.09% |
GSST | -7.66% | $857.21M | 0.16% |
IBMP | -6.83% | $531.75M | 0.18% |
GBIL | -5.88% | $6.17B | 0.12% |
FMF | -5.58% | $153.73M | 0.95% |
USFR | -5.11% | $18.91B | 0.15% |
AGGH | -4.88% | $309.35M | 0.29% |
CARY | -4.86% | $347.36M | 0.8% |
BSMW | -4.40% | $102.62M | 0.18% |
PHDG | -4.14% | $100.16M | 0.39% |
SHYM | -3.69% | $322.93M | 0.35% |
AGZD | -3.65% | $127.42M | 0.23% |
BILZ | -3.34% | $876.85M | 0.14% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DUSB | 0.08% | $1.20B | 0.15% |
TBLL | 0.30% | $2.46B | 0.08% |
KCCA | 0.51% | $97.18M | 0.87% |
JUCY | -0.62% | $297.77M | 0.6% |
LDUR | -0.72% | $849.09M | 0.5% |
STXT | 0.80% | $134.15M | 0.49% |
TUR | -0.86% | $139.51M | 0.59% |
XLP | 1.30% | $15.53B | 0.09% |
NEAR | -1.43% | $3.26B | 0.25% |
SPTS | 1.45% | $5.76B | 0.03% |
SMB | 1.50% | $269.10M | 0.07% |
FTXG | 1.54% | $34.98M | 0.6% |
FMHI | -1.58% | $757.44M | 0.7% |
XONE | -1.72% | $603.24M | 0.03% |
ITM | 1.76% | $1.97B | 0.18% |
BSCP | 1.77% | $3.49B | 0.1% |
GNMA | 1.81% | $355.60M | 0.1% |
IYK | -1.91% | $1.48B | 0.4% |
CGSM | 2.08% | $658.61M | 0.25% |
MMIN | 2.09% | $469.53M | 0.3% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FUBO | 43.01% | $1.01B | +121.80% | 0.00% |
PGEN | 33.31% | $386.67M | -6.43% | 0.00% |
BIPC | 32.70% | $4.63B | +11.39% | 4.22% |
BIP | 31.25% | $14.99B | +6.59% | 5.08% |
PBYI | 29.49% | $162.81M | -25.62% | 0.00% |
GPOR | 28.70% | $3.50B | +26.78% | 0.00% |
VHC | 28.45% | $34.69M | +74.89% | 0.00% |
CVAC | 28.43% | $771.16M | -1.58% | 0.00% |
CRK | 27.02% | $7.15B | +129.11% | 0.00% |
CRNT | 26.97% | $210.55M | -11.90% | 0.00% |
BNT | 26.72% | $11.98B | +33.22% | 0.00% |
AR | 26.53% | $12.49B | +17.80% | 0.00% |
ETN | 26.47% | $127.88B | -1.02% | 1.21% |
IGT | 26.44% | $3.36B | -19.66% | 4.83% |
APH | 26.24% | $103.99B | +30.54% | 0.70% |
GILT | 25.86% | $381.44M | +22.08% | 0.00% |
BB | 25.76% | $2.32B | +28.38% | 0.00% |
LOMA | 25.73% | $1.47B | +62.27% | 0.00% |
RRC | 25.47% | $9.63B | +9.18% | 0.82% |
ACET | 25.33% | $52.77M | -59.36% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
URGN | -0.01% | $454.16M | -25.44% | 0.00% |
MNKD | 0.02% | $1.39B | -0.65% | 0.00% |
BPT | -0.02% | $13.70M | -73.66% | 0.00% |
BJRI | 0.04% | $991.23M | +19.81% | 0.00% |
NKE | 0.04% | $92.10B | -32.00% | 2.46% |
CNP | -0.04% | $24.30B | +24.35% | 2.82% |
PPC | -0.04% | $11.21B | +41.54% | 0.00% |
PRSU | 0.05% | $858.41M | -14.40% | 0.00% |
SAVA | -0.06% | $99.03M | -90.49% | 0.00% |
LITB | -0.06% | $21.28M | -72.45% | 0.00% |
MSIF | -0.06% | $715.25M | +28.42% | 7.05% |
ENR | 0.06% | $1.71B | -23.26% | 5.03% |
ZBH | -0.07% | $19.14B | -20.21% | 0.99% |
GSHD | 0.08% | $2.73B | +81.29% | 0.00% |
FAX | 0.08% | - | - | 9.14% |
UDR | 0.08% | $13.88B | +6.29% | 4.08% |
KC | 0.10% | $3.55B | +273.03% | 0.00% |
API | 0.10% | $257.04M | +17.29% | 0.00% |
BAH | 0.11% | $16.17B | -16.31% | 1.64% |
WEC | 0.12% | $33.48B | +22.69% | 3.29% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DXCM | -15.68% | $33.59B | -35.05% | 0.00% |
CHD | -13.15% | $23.29B | -11.36% | 1.23% |
CLX | -11.86% | $16.64B | -1.45% | 3.61% |
PEP | -11.13% | $180.30B | -28.19% | 4.14% |
WHF | -9.90% | - | - | 17.11% |
GIS | -9.32% | $29.79B | -23.81% | 4.42% |
DVA | -8.37% | $10.84B | +5.22% | 0.00% |
CREG | -8.15% | $16.80M | -32.73% | 0.00% |
OPCH | -7.94% | $5.32B | +8.88% | 0.00% |
PG | -7.38% | $380.78B | -3.25% | 2.51% |
CBOE | -7.23% | $22.95B | +20.67% | 1.12% |
WEST | -7.20% | $705.08M | -30.05% | 0.00% |
HIHO | -6.63% | $8.25M | -10.29% | 3.73% |
AHCO | -6.10% | $1.22B | -8.22% | 0.00% |
KMB | -6.01% | $45.57B | +1.99% | 3.58% |
CATO | -5.93% | $54.69M | -48.22% | 12.06% |
AKRO | -5.56% | $3.19B | +92.76% | 0.00% |
AMGN | -5.28% | $146.09B | -13.67% | 3.40% |
OMER | -5.24% | $230.31M | +19.34% | 0.00% |
CAG | -5.22% | $10.87B | -26.52% | 6.17% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
HYDR | 30.86% | $26.84M | 0.5% |
IMOM | 29.99% | $90.83M | 0.39% |
TPIF | 28.81% | $138.55M | 0.62% |
GRID | 28.28% | $2.22B | 0.56% |
ISCF | 28.23% | $336.57M | 0.23% |
EWQ | 28.15% | $396.49M | 0.5% |
SCHF | 27.82% | $46.01B | 0.06% |
NUDM | 27.73% | $534.68M | 0.31% |
DFIS | 27.50% | $2.84B | 0.39% |
GWX | 27.44% | $666.69M | 0.4% |
SCHC | 27.33% | $4.19B | 0.11% |
EWC | 27.31% | $2.88B | 0.5% |
BBCA | 27.19% | $7.92B | 0.19% |
EZU | 27.18% | $7.90B | 0.51% |
FLCA | 26.97% | $416.90M | 0.09% |
EMXC | 26.93% | $15.43B | 0.25% |
SPEU | 26.92% | $864.01M | 0.07% |
VEA | 26.87% | $153.93B | 0.03% |
VSS | 26.84% | $8.61B | 0.07% |
SCZ | 26.81% | $9.92B | 0.4% |